Orexigen Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 60   

Articles published

OREX 5.54 -0.16 (-2.81%)
price chart
Is Orexigen Attractive Near 52-Week Lows?
Orexigen (OREX) is trading just 10% above 52-week lows at just over $5 per share as the week closes out. The company has been an interesting third play in the anti-obesity space despite the fact that, as yet, Contrave (the Orexigen anti-obesity drug ...
Stocks on the Run - Orexigen Therapeutics, Inc. (OREX), Aviat Networks Inc ...
Las Vegas, NV - April 23, 2014 - (TechSonian) �Orexigen Therapeutics, Inc.(NASDAQ:OREX)is a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity.
Related articles »  
Traders Watch list - Array Biopharma Inc (NASDAQ:ARRY), Orexigen ...
Orexigen Therapeutics, Inc. (NASDAQ:OREX) a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity.
Investor's Alert - Orexigen Therapeutics, Inc (NASDAQ:OREX), VIVUS, Inc ...
Las Vegas, NV - April 19, 2013 - (Tech Sonian) �Orexigen Therapeutics, Inc (NASDAQ:OREX) a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity.
Drug Losers: Prana Biotechnology Limited (NASDAQ:PRAN), Orexigen ...
On March 12,2014 Orexigen�Therapeutics, Inc. (Nasdaq:OREX), a biopharmaceutical company focused on the treatment of obesity, announced corporate and financial results for the fourth quarter and year ended December 31, 2013.
Related articles »  
Front Runners: Orexigen Therapeutics, Inc. (OREX), MagneGas Corporation ...
Manhattan, NY- April 18, 2014 - (Techsonian) - Orexigen Therapeutics, Inc. (NASDAQ:OREX) announced corporate and financial results for the fourth quarter and year ended December 31, 2013.
Investor's Watch List -Orexigen Therapeutics, Inc., Mitsubishi UFJ Financial ...
Orexigen Therapeutics, Inc.(NASDAQ:OREX)plunged-7.40% and closed at $5.13 on a traded volume of 3.06 million shares, in comparison to 2.31 million shares of average trading volume.
Related articles »  
Stocks in Focus - Halcon Resources Corp (NYSE:HK), Orexigen Therapeutics ...
Orexigen Therapeutics, Inc (NASDAQ:OREX) a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity.
Related articles »  
Investor's Watch List - Pharmacyclics, Inc. (PCYC), Vertex Pharmaceuticals ...
Orexigen Therapeutics, Inc. (NASDAQ:OREX) announced corporate and financial results for the fourth quarter and year ended December 31, 2013.
Related articles »  
Watch List: Array Biopharma Inc (ARRY), Orexigen Therapeutics, Inc. (OREX), Hi ...
Las Vegas, NV - April 11, 2014� (TechSonian) �Array Biopharma Inc (ARRY) focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases mainly in North America, ...
Related articles »